Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Molecure Logo
Molecure Growth Score
85
CB Rank
189000
Heat Score
71
Molecure is an innovative biopharmaceutical company that specializes in discovery, development, and commercialization of novel therapeutics.
Founded
obfuscation
PublicPost-IPO Secondary Warsaw, Mazowieckie, Poland51-100 molecure.com
Biopharma
Biotechnology
Therapeutics
Overview

Molecure
Total Funding
obfuscation
Growth Score
85
Heat Score
71

Total Funding
obfuscation
obfuscation
Post-IPO Secondary raised
obfuscation
Growth Score85
-7 pts
in past quarter
Heat Score 71
-4 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About Molecure

CB Rank
189000
Molecure is an innovative biopharmaceutical company that specializes in discovery, development, and commercialization of novel therapeutics.
Founded
obfuscation
PublicPost-IPO Secondary Warsaw, Mazowieckie, Poland51-100 molecure.com
Biopharma
Biotechnology
Therapeutics

Funding Rounds

Post-IPO Secondary
OBF
in
obfuscation

Key People

Details

Legal Name Molecure SA
Operating Status Active
Stock Symbol  WSE:MOC
Company Type For Profit
Founders  Adam Golebiowski
About the Company
Molecure is an innovative biopharmaceutical company that specializes in the discovery, development, and commercialization of novel therapeutics for inflammatory diseases.
Phone Number +48 22 552 67 24
Contact Email contact@molecure.com
Predictions & Insights

Products & Services

OATD-01
An oral, first-in-class chitotriosidase 1 (CHIT1) inhibitor for treating interstitial lung diseases like sarcoidosis and idiopathic pulmonary fibrosis.
OATD-02
An oral, selective dual arginase inhibitor targeting ARG1 and ARG2 enzymes for cancer treatment.

Research & Development

Molecure is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Secondary - Molecure Logo
Post-IPO Secondary - Molecure
—
obfuscation
— Post-IPO Secondary
obfuscation
Post-IPO Secondary - Molecure Logo
Post-IPO Secondary - Molecure
—
obfuscation
— Post-IPO Secondary
obfuscation
Post-IPO Secondary - Molecure Logo
Post-IPO Secondary - Molecure
—
obfuscation
— Post-IPO Secondary
obfuscation
Post-IPO Secondary - Molecure Logo
Post-IPO Secondary - Molecure
—
obfuscation
— Post-IPO Secondary
obfuscation
Post-IPO Secondary - Molecure Logo
Post-IPO Secondary - Molecure
—
obfuscation
— Post-IPO Secondary

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Secondary - Molecure Logo
Post-IPO Secondary - Molecure
—
obfuscation
— Post-IPO Secondary
obfuscation
Post-IPO Secondary - Molecure Logo
Post-IPO Secondary - Molecure
—
obfuscation
— Post-IPO Secondary
obfuscation
Post-IPO Secondary - Molecure Logo
Post-IPO Secondary - Molecure
—
obfuscation
— Post-IPO Secondary
obfuscation
Post-IPO Secondary - Molecure Logo
Post-IPO Secondary - Molecure
—
obfuscation
— Post-IPO Secondary
obfuscation
Post-IPO Secondary - Molecure Logo
Post-IPO Secondary - Molecure
—
obfuscation
— Post-IPO Secondary

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 51-100 Employee Profiles 1 Contacts 4

Employee Profiles

News

News and Press

News•Jun 11, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Oct 15, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jul 31, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 3, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

2,020
94.23%
 in past month

IT Spend

$778.6KThis year, Molecure is projected to spend $778.6K on IT, according to Aberdeen.

Active Website Tech Count

4Molecure is actively using 4 technologies for its website, according to BuiltWith. These include Common Crawl, CommonCrawl Top 5m, and  Amazon S3.

Total IP

14The intellectual property of Molecure includes 12 registered patents primarily in the 'Organic Chemistry' category, according to IPqwery. Additionally, Molecure has registered 2 trademarks with the most popular class being 'Scientific and technological services', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Molecure's headquarters? Molecure is located in Warsaw, Mazowieckie, Poland.When was the last funding round for Molecure? Molecure closed its last funding round on
obfuscation
from a Post-IPO Secondary round.Who are Molecure's competitors? Alternatives and possible competitors to Molecure may include Galderma, LEO Pharma, and  Aligos Therapeutics.How much funding has Molecure raised to date? Molecure has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(c22f898 1)
|